Editorial Commentary: Copper Homeostasis in Neurodegenerative Diseases
[1] | Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science, 2022,375(6586):1254–1261 |
[2] | Ban XX, Wan H, Wan XX, et al. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases. Curr Med Sci, 2024,44(1):28–50 |
[3] | Cobine PA, Moore SA, Leary SC. Getting out what you put in: Copper in mitochondria and its impacts on human disease. Biochim Biophys Acta Mol Cell Res, 2021,1868(1):118867 |
[4] | Tian Z, Jiang S, Zhou J, et al. Copper homeostasis and cuproptosis in mitochondria. Life Sci, 2023,334:122223 |
[5] | Garza NM, Swaminathan AB, Maremanda KP, et al. Mitochondrial copper in human genetic disorders. Trends Endocrinol Metab, 2023,34(1):21–33 |
[6] | Wang Z, Jin D, Zhou S, et al. Regulatory roles of copper metabolism and cuproptosis in human cancers. Front Oncol, 2023,13:1123420 |
[7] | Gromadzka G, Tarnacka B, Flaga A, et al. Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications. Int J Mol Sci, 2020,21(23): 9259 |
[8] | Yang Y, Li ZX, Hu XM, et al. Insight into Crosstalk Between Mitophagy and Apoptosis/Necroptosis: Mechanisms and Clinical Applications in Ischemic Stroke. Curr Med Sci, 2022,42(2):237–248 |
[9] | Wan H, Yan Y, Hu XM, et al. Inhibition of mitochondrial VDAC1 oligomerization alleviates apoptosis and necroptosis of retinal neurons following OGD/R injury. Ann Anat, 2023,247:152049 |
[10] | Yan WT, Zhao WJ, Hu XM, et al. PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons. Neural Regen Res, 2023,18(2):357–363 |
[11] | Chen X, Tian PC, Wang K, et al. Pyroptosis: Role and Mechanisms in Cardiovascular Disease. Front Cardiovasc Med, 2022,9:897815 |
[12] | Zhou Z, Shang L, Zhang Q, et al. DTX3L induced NLRP3 ubiquitination inhibit R28 cell pyroptosis in OGD/R injury. Biochimica Et Biophysica Acta Mol Cell Res, 2023,1870(3):119433 |
[13] | Chen J, Wang Y, Li M, et al. Netrin-1 Alleviates Early Brain Injury by Regulating Ferroptosis via the PPARγ/Nrf2/GPX4 Signaling Pathway Following Subarachnoid Hemorrhage. Transl Stroke Res, 2024,15(1):219–237 |
[14] | Ju J, Li XM, Zhao XM, et al. Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia/reperfusion injury by interacting with NAMPT. J Biomed Sci, 2023,30(1):45 |
[15] | Wang K, Chen XZ, Wang YH, et al. Emerging roles of ferroptosis in cardiovascular diseases. Cell Death Discov, 2022,8(1):394 |
[16] | Wan H, Yang Y, Zhang Q, et al. VDAC1, as a downstream molecule of MLKL, participates in OGD/R-induced necroptosis by inducing mitochondrial damage. Heliyon, 2024,10(1):e23426 |
[17] | Zhang Q, Hu XM, Zhao WJ, et al. Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases. Int J Biol Sci, 2023,19(2):658–674 |
[18] | Gao XQ, Liu CY, Zhang YH, et al. The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression. Cell Death Diff, 2022,29(3):527–539 |
[19] | Chen X, Cai Q, Liang R, et al. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis, 2023,14(2):105 |
[20] | Li X, Chen X, Gao X. Copper and cuproptosis: new therapeutic approaches for Alzheimer’s disease. Front Aging Neurosci, 2023,15:1300405 |
[21] | Jia F, Zhang B, Yu W, et al. Exploring the cuproptosis-related molecular clusters in the peripheral blood of patients with amyotrophic lateral sclerosis. Comput Biol Med, 2024,168:107776 |
[22] | Baj J, Flieger W, Barbachowska A, et al. Consequences of Disturbing Manganese Homeostasis. Int J Mol Sci, 2023,24(19):14959 |
[23] | Kalita S, Kalita S, Kawa AH, et al. Copper chelating cyclic peptidomimetic inhibits Aβ fibrillogenesis. RSC Med Chem, 2022,13(6):761–774 |
[24] | Wang Q, Sun J, Chen T, et al. Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer’s Disease. ACS Chem Neurosci, 2023,14(19):3564–3587 |
[25] | Liu N, Chen M. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application. Biomed Pharmacother, 2024,171:116115 |
[26] | Xue Q, Yan D, Chen X, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy, 2023,19(7):1982–1996 |
/
〈 | 〉 |